|
|
|
LifeScienceHistory.com - Check us out on Instagram
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Myovant Sciences, Inc.
| | | Phone: | (650) 238-0250 | Year Established: | 2016 | Ticker: | MYOV | Exchange: | NYSE | Main Contact: | Lynn Seely, MD, President & CEO | | Other Contacts: | Bryan Selby, VP, Product Development Matthew Lang, JD, General Counsel Teresa Perney, PhD, Senior VP, RA & QA Frank Karbe, CFO Juan Camilo Arjona Ferreira, MD, CMO
| | Company Description | Myovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women's health and endocrine diseases. Myovant's lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist. | |
|
|
|
|
|